Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT03943537
PHASE2
Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders
Sponsor: Mclean Hospital
View on ClinicalTrials.gov
Summary
This clinical trial is a single center, single dose study of the acute effects of intranasal insulin on energy metabolism and cognitive function in patients with schizophrenia, schizoaffective and bipolar disorders, compared and healthy controls.
Key Details
Gender
All
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
87
Start Date
2019-10-01
Completion Date
2024-02-23
Last Updated
2026-09-03
Healthy Volunteers
Yes
Interventions
DRUG
Intranasal Insulin
40 units Novolin R administered intranasally using ViaNase device.
Locations (1)
McLean Hospital
Belmont, Massachusetts, United States